Diabetes Drug Lawsuit Gets Class-Action Status
The state Supreme Court gave class-action status to lawsuits against Warner-Lambert Co., the maker of the diabetes drug Rezulin, which was pulled three years ago because of liver-related deaths.
The court reversed a decision by Raleigh County Circuit Judge John A. Hutchison, who denied the plaintiffs’ class-action request in 2001 and ruled that tests did not conclusively prove the drug caused liver damage.
Hutchison will now hear the case brought on behalf of up to 5,000 West Virginians to recover the costs of determining whether they were injured by the drug.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
